Cite

HARVARD Citation

    Hussain, M. et al. (2019). Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma. British journal of haematology. pp. 140-144. [Online]. 
  
Back to record